PVCT today
$0.07+$0.00 (+1.53%)close Jun 25, 2026Trend
—
Key levels
—
Latest news & SEC filings
SEC FilingProvectus Biopharmaceuticals, Inc. filed an insider trading report (Form 4)
All PVCT news →OTC · Healthcare
PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT)
What Is the Price Target for PVCT?
SEPT Low Target
$0.00
SEPT Mid Target
$0.00
SEPT High Target
$0.00
Analyst Consensus
$0.00
Is PVCT a Buy or Sell Right Now?
Thesis
- •Revenue growing -45.5% YoY with DECLINING trend — consistent growth.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for PVCT.
Start Free Trial →Is PVCT Overvalued or Undervalued?
Valuation Verdict
N/A
Methods Used
N/A
Fair Value
$N/A
18
Moat Score
NONE
1/9
Piotroski Score
-560.3
Altman Z-Score
What Is Smart Money Doing with PVCT?
Insider Signal
NEUTRAL
0 buys / 0 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
MEDIUM
Signal: NEUTRAL
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →PVCT Growth Story
Revenue YoY
-45.5%
3yr Revenue CAGR
-30.2%
EPS Growth YoY
0%
FCF Growth YoY
N/A%
Revenue Trend
DECLINING
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →PVCT — frequently asked questions
What is PVCT stock price today?
PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) is at $0.07, up 1.53% (+$0.00) at the Jun 25, 2026 close.
Why is PVCT stock moving today?
Latest PVCT news — Nov 9, 2026: Provectus Biopharmaceuticals, Inc. filed an insider trading report (Form 4)
Did PVCT beat earnings?
PVCT last reported on Aug 13, 2026: EPS -$0.00.
Does PVCT pay a dividend?
PVCT does not currently pay a dividend.
What are insiders doing with PVCT?
Insider activity: NEUTRAL, 0 buys and 0 sells in the last 90 days.
What is the latest news on PVCT?
Nov 9, 2026: Provectus Biopharmaceuticals, Inc. filed an insider trading report (Form 4)